CSWM
IMVT icon

Cassady Schiller Wealth Management’s Immunovant IMVT Stock Holding History

Cassady Schiller Wealth Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$50 Buy
+2
New +$57 ﹤0.01% 1130

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Cassady Schiller Wealth Management's IMVT Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Immunovant (IMVT) in Q4 2024: 2 shares worth $50. The stake represents ﹤0.01% of the portfolio and ranks #1130 among its holdings.

186 funds tracked by Wall St. Rank hold IMVT as of Q4 2024.

  • Cassady Schiller Wealth Management held 2 shares of Immunovant worth $50 as of Q4 2024.
  • Immunovant was a new Cassady Schiller Wealth Management position in Q4 2024.
  • Immunovant made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #1130 holding.
  • 186 funds tracked by Wall St. Rank held Immunovant as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.